Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) General Information

Description

Manufacturer and seller of bio pharmaceutical products. The company is engaged in researching, developing and manufacturing drugs, medical supplies and other medical equipment.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Acquirer
IDT Biologika
Primary Office
  • 1405 Research Boulevard
  • Rockville, MD 20850
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center)‘s full profile, request access.

Request a free trial

Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center)‘s full profile, request access.

Request a free trial